Risk Of Corticosteroid-Related Adverse Events In Patients With Asthma With 30 Days Or More Of Annual Oral Corticosteroid Exposure

被引：0
|
作者：
Raimundo, K. [1 ]
Broder, M. [2 ]
Omachi, T. [1 ]
Chang, E. [2 ]
Sun, G. [2 ]
Zazzali, J. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Partnership Hlth Analyt Res LLC, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1337
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use
    Zazzali, James L.
    Broder, Michael S.
    Omachi, Theodore A.
    Chang, Eunice
    Sun, Gordon H.
    Raimundo, Karina
    ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (04) : 268 - 274
  • [2] Strategies to reduce corticosteroid-related adverse events in asthma
    Heffler, Enrico
    Bagnasco, Diego
    Canonica, Giorgio W.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (01) : 61 - 67
  • [3] Corticosteroid-related adverse outcomes costly in asthma
    Reactions Weekly, 2018, 1712 (1) : 8 - 8
  • [4] Oral corticosteroid-related adverse events cost UK £84 million
    Reactions Weekly, 2009, 1263 (1) : 4 - 4
  • [5] Corticosteroid-Related Adverse Events in Chronic Idiopathic Urticaria
    Ledford, Dennis
    Broder, Michael
    Antonova, Evgeniya
    Solari, Paul
    Omachi, Theodore A.
    Chang, Eunice
    Sun, Gordon H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB125 - AB125
  • [6] Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis
    Suhler, Eric B.
    Thorne, Jennifer E.
    Mittal, Manish
    Betts, Keith A.
    Tari, Samir
    Camez, Anne
    Bao, Yanjun
    Joshi, Avani
    OPHTHALMOLOGY, 2017, 124 (12) : 1799 - 1807
  • [7] Impact of Dosing and Duration of Dexamethasone on Serious Corticosteroid-Related Adverse Events
    An, Amy W.
    Chen, Xi
    Urbauer, Diana L.
    Bruera, Eduardo
    Hui, David
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (01) : 59 - 68
  • [8] Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma
    Heffler, E.
    Sirena, C.
    Ferrando, M.
    Di Matteo, S.
    Martinotti, C.
    Bruno, G. M.
    Colombo, G.
    Latorre, M.
    D'Adda, A.
    Mantero, M.
    Paggiaro, P.
    Blasi, F.
    Canonica, G. W.
    ALLERGY, 2018, 73 : 528 - 528
  • [9] Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
    Broder, Michael S.
    Sarsour, Khaled
    Chang, Eunice
    Collinson, Neil
    Tuckwell, Katie
    Napalkov, Pavel
    Klearman, Micki
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (02) : 246 - 252
  • [10] ORAL CORTICOSTEROID-RELATED HEALTHCARE RESOURCE UTILISATION IN PATIENTS WITH COPD
    Tse, G.
    Anti, C.
    Bafadhel, M.
    papi, A.
    Carter, V.
    Zhou, J.
    Skinner, D.
    Xu, X.
    Mullerova, H.
    Emmanuel, B.
    Price, D.
    THORAX, 2022, 77 : A195 - A196
12345